Tango Therapeutics, Inc. (TNGX)
21.86
+0.64
(+3.02%)
USD |
NASDAQ |
Apr 02, 10:39
Tango Therapeutics Research and Development Expense (TTM) : 130.51M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 978.68M |
| Kodiak Sciences, Inc. | 182.37M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| AbbVie, Inc. | 9.096B |
| Teleflex, Inc. | 180.89M |